Angiogenesis and bleeding disorders in FNAIT

Oncotarget

Volumn 6, Issue 18, 2015, Pages 15724-15725

  Yougbare, Issaka ^b   Zdravic, Darko ^b   Ni, Heyu ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; FC RECEPTOR; HUMAN PLATELET ANTIGEN 1A; IMMUNOGLOBULIN; PROTEIN KINASE B; THROMBOCYTE ANTIGEN; TRANSCRIPTION FACTOR NF E2; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; APOPTOSIS; BLEEDING DISORDER; BRAIN HEMORRHAGE; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CROSS REACTION; DISEASE COURSE; DOWN REGULATION; EDITORIAL; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN TARGETING; THROMBOCYTOPENIA; TROPHOBLAST; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BLOOD; DISEASE MODEL; MOUSE; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84937832184     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4757     Document Type: Editorial

References (7)

1. Brooks, P.C. et al. Cell, 1994; 79:1157-1164.
2. Reynolds L.E. et al. Nat Med. 2002; 8:27-34.
3. Palumbo J.S. et al. 2004; J Thromb Haemost 2:1368-1379.4.
4. Yougbaré I. et al. J Clin Invest. 2015; 125:1545-56.
5. Ni H. et al. Blood. 2006; 107:2976-2983.
6. Chen P. et al. Blood. 2010; 116:3660-3668.
7. Li C. et al. J Clin Invest. 2011; 121:4537-4547.